Related Experiment Videos
[Microscopic polyangiitis]
Abstract:
Microscopic polyangiitis is a systemic necrotizing vasculitis affecting small vessels, without granulomata. Patients present with rapidly progressive glomerulonephritis, often associated with cutaneous, musculoskeletal, neurological or gastrointestinal involvement. Antineutrophilcytoplasmic antibodies are frequently found, most often with a perinuclear pattern and a antimyeloperoxidase specificity. Diagnosis is based on the evidence of a necrotizing glomerulonephritis, or histological vasculitis, in the absence of extravascular granulomata or sign of macroscopic polyarteritis nodosa. Corticosteroids and immunosuppressive drugs have improved the prognosis, but relapses are frequent.
Insights
Microscopic polyangiitis is a systemic vasculitis affecting small vessels, leading to rapidly progressive glomerulonephritis. While treatments improve prognosis, frequent relapses remain a challenge for patients with this condition.
Area of Science:
- Rheumatology and Nephrology
- Systemic autoimmune diseases
- Small vessel vasculitis
Context:
- Microscopic polyangiitis (MPA) is a rare systemic necrotizing vasculitis.
- It primarily affects small blood vessels, distinguishing it from other vasculitic syndromes.
- MPA commonly presents with severe kidney involvement, specifically rapidly progressive glomerulonephritis.
Purpose:
- To define the key characteristics of microscopic polyangiitis.
- To outline diagnostic criteria for MPA.
- To discuss current therapeutic approaches and their limitations.
Summary:
- MPA involves systemic necrotizing vasculitis of small vessels without granulomata.
- Clinical manifestations include rapidly progressive glomerulonephritis and potential involvement of skin, muscles, nerves, and gastrointestinal tract.
- Antineutrophil cytoplasmic antibodies (ANCAs), often antimyeloperoxidase (MPO)-ANCA positive, are frequently detected.
Impact:
- Diagnosis relies on identifying necrotizing glomerulonephritis or vasculitis histologically, excluding granulomata and polyarteritis nodosa.
- Corticosteroids and immunosuppressants have improved patient outcomes.
- Despite treatment advances, the high frequency of disease relapses necessitates ongoing research and management strategies.